(Q39163420)

9 September 2017

title

New World cutaneous leishmaniasis in returned travellers: treatment failures using intravenous sodium stibogluconate (English)

1 reference

9 September 2017

main subject

cutaneous leishmaniasis

1 reference

mucocutaneous leishmaniasis

inferred from title

1 reference

Lawn SD

1

1 reference

9 September 2017

Yardley V

2

1 reference

9 September 2017

Vega-Lopez F

3

1 reference

9 September 2017

Watson J

4

1 reference

9 September 2017

Lockwood DN

5

1 reference

9 September 2017

publication date

1 July 2003

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

9 September 2017

published in

1 reference

9 September 2017

volume

97

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

443-445

1 reference

Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2990084-8

7 January 2021

Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2990084-8

7 January 2021

Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2990084-8

7 January 2021

Diagnosis of New World leishmaniasis: specific detection of species of the Leishmania braziliensis complex by amplification of kinetoplast DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2990084-8

7 January 2021

Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2990084-8

7 January 2021

Placebo Controlled Treatment of Ecuadorian Cutaneous Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2990084-8

7 January 2021

Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2990084-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2990084-8

1 reference

7 January 2021

Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2990084-8

7 January 2021

A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2990084-8

7 January 2021

Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2990084-8

7 January 2021

10.1016/S0035-9203(03)90084-8

Identifiers

DOI

1 reference

9 September 2017

1 reference